![Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF](https://i1.rgstatic.net/ii/profile.image/11431281168597271-1687027140720_Q64/Roy-Fleischmann.jpg)
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF
![Initiation of transdermal opioid therapy in cancer patients with moderate or severe malignant pain - Treatment patterns and costs in a German university hospital | Request PDF Initiation of transdermal opioid therapy in cancer patients with moderate or severe malignant pain - Treatment patterns and costs in a German university hospital | Request PDF](https://i1.rgstatic.net/ii/profile.image/272734898880518-1442036475563_Q64/Anton-Megens.jpg)
Initiation of transdermal opioid therapy in cancer patients with moderate or severe malignant pain - Treatment patterns and costs in a German university hospital | Request PDF
![Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF](https://i1.rgstatic.net/ii/profile.image/1182367704186884-1658909836358_Q64/Andrew_Moore65.jpg)
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF
![Initiation of transdermal opioid therapy in cancer patients with moderate or severe malignant pain - Treatment patterns and costs in a German university hospital | Request PDF Initiation of transdermal opioid therapy in cancer patients with moderate or severe malignant pain - Treatment patterns and costs in a German university hospital | Request PDF](https://i1.rgstatic.net/ii/profile.image/277057511673865-1443067066552_Q64/Francis-Ruiz-2.jpg)
Initiation of transdermal opioid therapy in cancer patients with moderate or severe malignant pain - Treatment patterns and costs in a German university hospital | Request PDF
![Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF](https://i1.rgstatic.net/ii/profile.image/1092574538412035-1637501477632_Q64/Francisco-Leyva-3.jpg)
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF
![A Systematic Review of Economic Evaluation Studies of Drug-Based Non-Malignant Chronic Pain Treatment | Request PDF A Systematic Review of Economic Evaluation Studies of Drug-Based Non-Malignant Chronic Pain Treatment | Request PDF](https://i1.rgstatic.net/ii/profile.image/11431281098881538-1669132161309_Q64/Jacqueline-Lucas-2.jpg)
A Systematic Review of Economic Evaluation Studies of Drug-Based Non-Malignant Chronic Pain Treatment | Request PDF
![Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF](https://i1.rgstatic.net/ii/profile.image/1155371792121857-1652473509392_Q64/Hung-Fung.jpg)
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF
![Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF](https://i1.rgstatic.net/ii/profile.image/713910084702218-1547220836740_Q64/Sairam-Atluri.jpg)
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF
![Initiation of transdermal opioid therapy in cancer patients with moderate or severe malignant pain - Treatment patterns and costs in a German university hospital | Request PDF Initiation of transdermal opioid therapy in cancer patients with moderate or severe malignant pain - Treatment patterns and costs in a German university hospital | Request PDF](https://i1.rgstatic.net/ii/profile.image/293821888909315-1447064005814_Q64/Karen-Bloor.jpg)
Initiation of transdermal opioid therapy in cancer patients with moderate or severe malignant pain - Treatment patterns and costs in a German university hospital | Request PDF
![Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF](https://i1.rgstatic.net/ii/profile.image/11431281167207429-1686604256125_Q64/Ben-Hout.jpg)
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF
![Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF](https://i1.rgstatic.net/ii/profile.image/1130957365084162-1646652656445_Q64/Gwendolyn-Schmitt.jpg)
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF
![Initiation of transdermal opioid therapy in cancer patients with moderate or severe malignant pain - Treatment patterns and costs in a German university hospital | Request PDF Initiation of transdermal opioid therapy in cancer patients with moderate or severe malignant pain - Treatment patterns and costs in a German university hospital | Request PDF](https://i1.rgstatic.net/ii/profile.image/272186359414797-1441905693347_Q64/Guenka-Petrova.jpg)
Initiation of transdermal opioid therapy in cancer patients with moderate or severe malignant pain - Treatment patterns and costs in a German university hospital | Request PDF
![Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF](https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg)
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF
![A Systematic Review of Economic Evaluation Studies of Drug-Based Non-Malignant Chronic Pain Treatment | Request PDF A Systematic Review of Economic Evaluation Studies of Drug-Based Non-Malignant Chronic Pain Treatment | Request PDF](https://i1.rgstatic.net/ii/profile.image/1169422857314305-1655823544180_Q64/Kieran-Dalton.jpg)
A Systematic Review of Economic Evaluation Studies of Drug-Based Non-Malignant Chronic Pain Treatment | Request PDF
![Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF](https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg)
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone | Request PDF
![A Systematic Review of Economic Evaluation Studies of Drug-Based Non-Malignant Chronic Pain Treatment | Request PDF A Systematic Review of Economic Evaluation Studies of Drug-Based Non-Malignant Chronic Pain Treatment | Request PDF](https://i1.rgstatic.net/ii/profile.image/914371395985409-1595014537435_Q64/Richard-Lipton.jpg)
A Systematic Review of Economic Evaluation Studies of Drug-Based Non-Malignant Chronic Pain Treatment | Request PDF
![Initiation of transdermal opioid therapy in cancer patients with moderate or severe malignant pain - Treatment patterns and costs in a German university hospital | Request PDF Initiation of transdermal opioid therapy in cancer patients with moderate or severe malignant pain - Treatment patterns and costs in a German university hospital | Request PDF](https://i1.rgstatic.net/ii/profile.image/273608077475849-1442244657310_Q64/Lukas-Radbruch.jpg)
Initiation of transdermal opioid therapy in cancer patients with moderate or severe malignant pain - Treatment patterns and costs in a German university hospital | Request PDF
![A Systematic Review of Economic Evaluation Studies of Drug-Based Non-Malignant Chronic Pain Treatment | Request PDF A Systematic Review of Economic Evaluation Studies of Drug-Based Non-Malignant Chronic Pain Treatment | Request PDF](https://i1.rgstatic.net/ii/profile.image/11431281156287438-1683478481864_Q64/Nancy-Neil.jpg)